Search

Your search keyword '"phase 2 clinical trial"' showing total 93 results

Search Constraints

Start Over You searched for: Descriptor "phase 2 clinical trial" Remove constraint Descriptor: "phase 2 clinical trial" Topic human Remove constraint Topic: human
93 results on '"phase 2 clinical trial"'

Search Results

1. Levels of proteolytic activities as intermediate marker endpoints in oral carcinogenesis.

2. A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology

3. Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

4. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

5. Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasms.

6. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

7. The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

8. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.

9. Why phase II trials in cervical chemoprevention are negative: what have we learned?

10. Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157).

11. Development of difluoromethylornithine as a chemoprevention agent for the management of colon cancer.

12. Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas

13. Phase II study of recombinant alpha-interferon in malignant melanoma.

14. Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma.

15. A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

16. Single-Dose Tafenoquine to Prevent Relapse ofPlasmodium vivaxMalaria

17. Sustainability of and Adherence to Preschool Health Promotion Among Children 9 to 13 Years Old

18. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): A randomised, placebo controlled, phase 2 trial

19. A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma.

20. Clinical experience with topical tretinoin in the treatment of cervical dysplasia.

21. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial.

22. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.

23. CHALLENGES IN ACHIEVING MARKET ACCESS SUCCESS FOR ADVANCED THERAPIES IN EUROPE: A CASE STUDY

24. Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients : Follow-up from the ARADES and ARAFOR Trials

25. CHALLENGES IN ACHIEVING MARKET ACCESS SUCCESS FOR ADVANCED THERAPIES IN EUROPE: A CASE STUDY

26. Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children

27. Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial

28. Gas chromatographic quadrupole time-of-flight full scan high resolution mass spectrometric screening of human urine in antidoping analysis

29. Safety and antitumour activity of ODM-201 (BAY-1841788) in castration-resistant, CYP17 inhibitor-naïve prostate cancer : results from extended follow-up of the ARADES Trial

30. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase

31. Pasireotide in dumping syndrome-results from a phase 2, international, multicentre study

32. Efficacy and safety assessment of the addition of bevacizumab to adjuvant therapy agents in cancer patients: A systematic review and meta-analysis of randomized controlled trials

33. Phase II Study of Induction Chemotherapy with Gemcitabine plus 5-Fluorouracil Followed by Gemcitabine-Based Concurrent Chemoradiotherapy for Unresectable Locally Advanced Pancreatic Cancer

34. Treatment of Metastatic Pancreatic Cancer with a Combination of Gemcitabine and 5-Fluorouracil: A Single Center Phase II Study

35. Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer

36. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

37. Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9

38. Pasireotide in dumping syndrome-results from a phase 2, international, multicentre study

39. First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

40. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi

41. EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group

42. Population pharmacokinetics of cutamesine in rats using NONMEM, 11C-SA4503, and microPET

43. Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study

44. A new antiviral drug triazavirin: results of phase II clinical trial

45. Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

46. Docetaxel (TaxotereTM), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study

47. Potentiation of a P53-SLP vaccine by cyclophosphamide in ovarian cancer, A single ARM phase II study

48. Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

49. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

50. Gene therapy for immunodeficiency due to adenosine deaminase deficiency

Catalog

Books, media, physical & digital resources